Gabapentin Tablet
Product Images NDC 67877-428

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 67877-428). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-600mg-100s (Gabapentin 600mg 100s)

FDA Label Image

Gabapentin-800mg-100s (Gabapentin 800mg 100s)

FDA Label Image

Gabapentin Equation (Gabapentin Equation)

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

Gabapentin-fig1 (Gabapentin Fig1)
This appears to be a chart or table showing the mean pain score for patients during a 4-week dose titration period and a 4-week fixed dose period. The scores are given for a placebo group and a group taking 3600 mg/day of Gabapentin. It is not clear what the context or purpose of this chart is.*
FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

Gabapentin-fig2 (Gabapentin Fig2)
This appears to be a chart or table displaying mean pain scores at various points in time during a study evaluating the effects of gabapentin on pain. The study had a four-week fixed dose period and included a placebo group, a group receiving 1800 mg/day of gabapentin, and a group receiving 2400 mg/day of gabapentin. The chart shows baseline scores and scores at one or more subsequent weeks.*
FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

FDA Label Image

Gabapentin-structure (Gabapentin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.